Crinetics Pharmaceuticals, Inc. 3 SEC Filings

Filed On	Filing
05 Mar 2025	Form 3: Schilke Tobin, Chief Financial Officer No securities owned
30 Dec 2024	Form 3: Kalofonos Isabel, Chief Commercial Officer No securities owned
11 Oct 2022	Form 3: Pizzuti Dana, Chief Development Officer No securities owned
14 Mar 2022	Form 3: Deardorf Caren, Director No securities owned
09 Mar 2022	Form 3: Hassard James, Chief Commercial Officer No securities owned
10 Jan 2022	Form 3: Vivaldi Coelho Rogerio, Director No securities owned
19 Oct 2021	Form 3: Betz Stephen F., Chief Scientific Officer Holds 187,925 shares of Common Stock
02 Sep 2021	Form 3: Knight Jeff E., Chief Operating Officer No securities owned
03 Sep 2020	Form 3: Bedrosian Camille L, Director No securities owned
27 Mar 2020	Form 3: Madan Ajay, Chief Development Officer Holds 76,046 shares of Common Stock
16 Jul 2019	Form 3: Okey Stephanie, Director No securities owned
17 Jul 2018	Form 3: Nichols Weston, Director No securities owned
17 Jul 2018	Form 3: Struthers Richard Scott, Director Holds 1,215,805 shares of Common Stock
17 Jul 2018	Form 3: Kaldor Stephen W, Director
17 Jul 2018	Form 3: Wierenga Wendall, Director Holds 74,517 shares of Common Stock
17 Jul 2018	Form 3: Orbimed Advisors Llc, 10% owner and 1 other
17 Jul 2018	Form 3: Fust Matthew K, Director Holds 12,536 shares of Common Stock
17 Jul 2018	Form 3: Krasner Alan Seth, Chief Medical Officer
17 Jul 2018	Form 3: Freeman Mason, Director
17 Jul 2018	Form 3: Wilson Marc, See Remarks Holds 55,851 shares of Common Stock

Comments